Du verkar använda en bredare skärm. Vill du aktivera en bredare visningsupplevelse på denna sida?
Herantis Pharma as an Investment | Life Science Night Dec 9, 2025

Av Inderes
Antti Vuolanto, CEO, talks about biotechnology company Herantis Pharma as an investment.
Life Science Night 2025
- Keynote – Antti Siltanen, Inderes (link)
- Orion Pharma – Tuukka Hirvonen, Head of Investor Relations (link)
- Aiforia – Jukka Tapaninen, CEO (link)
- Herantis Pharma – Antti Vuolanto, CEO (link)
Life Science Night December 9, 2025 (link)
Life Science Night December 2, 2024 (link)